ABRP infections | Non-ARP infections | No infections | P-value | |
---|---|---|---|---|
Population overall (N = 351) | N = 58 | N = 57 | N = 236 | |
Intra-ICU outcomes | ||||
Critical Illness Myopathy | 22 (37.9) | 11 (19.3) | 9 (3.8) | < 0.001 |
Tracheostomy on discharge | 19 (15.5) | 11 (19.3) | 8 (3.4) | < 0.001 |
Length of stay, days | 29.6 ± 21.1 | 16.6 ± 13.6 | 6.6 ± 7.7 | < 0.001a,b,c |
MV days | 23.3 ± 17.6 | 13.1 ± 10.8 | 4.6 ± 6.7 | < 0.001a,b,c |
ICU cost/patient, euros | 13,515 ± 7761 | 8330 ± 5698 | 4183 ± 3877 | < 0.001a,b,c |
Intra-ICU mortality | 24 (41.4) | 18 (31.6) | 56 (23.7) | 0.022 |
Post-ICU outcomes | ||||
90-day mortality | 42 (72.4) | 33 (57.9) | 109 (46.2) | 0.001 |
2-year mortality | 46 (79.3) | 37 (64.9) | 133 (56.36) | 0.005 |
0.5-year QALYs | 0.041 ± 0.085 | 0.073 ± 0.106 | 0.057 ± 0.097 | 0.077 |
1-year QALYs | 0.105 ± 0.219 | 0.180 ± 0.265 | 0.142 ± 0.245 | 0.098 |
1.5-year QALYs | 0.167 ± 0.358 | 0.289 ± 0.433 | 0.228 ± 0.4 | 0.101 |
2-year QALYs | 0.228 ± 0.501 | 0.399 ± 0.604 | 0.313 ± 0.559 | 0.101 |
ICU survivors (N = 253) | N = 34 | N = 39 | N = 180 | |
90-day mortality | 18 (52.9) | 15 (38.5) | 53 (29.4) | 0.024 |
2-year mortality | 22 (64.7) | 19 (48.7) | 103 (57.2) | 0.061 |
0.5-year QALYs | 0.070 ± 0.102 | 0.107 ± 0.113 | 0.159 ± 0.142 | 0.001b |
1-year QALYs | 0.179 ± 0.263 | 0.264 ± 0.285 | 0.380 ± 0.341 | 0.002 b |
1.5-year QALYs | 0.285 ± 0.432 | 0.423 ± 0.468 | 0.594 ± 0.543 | 0.003 b |
2-year QALYs | 0.389 ± 0.608 | 0.584 ± 0.654 | 0.808 ± 0.747 | 0.004 b |